NDC 0270-7025

Vueway

Gadopiclenol

Vueway is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Bracco Diagnostics Inc. The primary component is Gadopiclenol.

Product ID0270-7025_26aa626c-965d-4587-9046-03e601ae57ba
NDC0270-7025
Product TypeHuman Prescription Drug
Proprietary NameVueway
Generic NameGadopiclenol
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-09-21
Marketing CategoryNDA /
Application NumberNDA216986
Labeler NameBRACCO DIAGNOSTICS INC
Substance NameGADOPICLENOL
Active Ingredient Strength485 mg/mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0270-7025-40

10 VIAL, SINGLE-DOSE in 1 CASE (0270-7025-40) > 7.5 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-09-21
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Vueway" or generic name "Gadopiclenol"

NDCBrand NameGeneric Name
0270-7015VuewayGadopiclenol
0270-7020VuewayGadopiclenol
0270-7025VuewayGadopiclenol
0270-7030VuewayGadopiclenol
0270-7035VuewayGadopiclenol
67684-4230ELUCIREMgadopiclenol
67684-4231ELUCIREMgadopiclenol
67684-4232ELUCIREMgadopiclenol
67684-4233ELUCIREMgadopiclenol
67684-4240ELUCIREMgadopiclenol
67684-4241ELUCIREMgadopiclenol
67684-4242ELUCIREMgadopiclenol
67684-4250ELUCIREMgadopiclenol

Trademark Results [Vueway]

Mark Image

Registration | Serial
Company
Trademark
Application Date
VUEWAY
VUEWAY
97222742 not registered Live/Pending
BRACCO IMAGING S.p.A.
2022-01-17
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.